EMLA Cream 5% is a topical anesthetic that combines lidocaine and prilocaine to effectively numb the skin for medical procedures.
The Marketing Authorization Holder for EMLA Cream 5% is Aspen Pharma Trading Limited, based in Dublin, Ireland. The product is manufactured by Recipharm Karlskoga AB, located in Karlskoga, Sweden, leveraging their expertise in pharmaceutical production.
Aspen Pharma Trading Limited is part of Aspen Pharmacare, a global pharmaceutical leader headquartered in South Africa. Aspen Pharmacare is renowned for its extensive portfolio of high-quality pharmaceutical products, catering to diverse healthcare needs worldwide.